Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.
J Cyst Fibros. 2016 Jul;15(4):479-85. doi: 10.1016/j.jcf.2015.09.005. Epub 2015 Sep 26.
We aimed to estimate the prevalence of different Achromobacter species among UK Cystic Fibrosis (CF) patients.
nrdA sequence clustering was used to identify 147 Achromobacter isolates from 96 patients from 27 hospitals to species level. Potential cross-infection was investigated by MLST, pulsed-field gel electrophoresis and whole genome sequencing (WGS).
Achromobacter xylosoxidans was the most prevalent species affecting 59 of 96 (61%) patients, followed by Achromobacter insuavis and Achromobacter dolens (12.4% and 8%, respectively). Three novel nrdA clusters were identified. One was further characterised by sequencing the intrinsic blaOXA gene, revealing novel variants. WGS of A. insuavis 2a isolates from four patients attending the same paediatric unit revealed that three were ST144, but differed from one another by a minimum of 385 SNPs, suggesting cross-infection was unlikely.
nrdA sequence clustering permitted an estimation of UK Achromobacter species prevalence, highlighted additional novel species, and aided cross-infection investigations.
我们旨在估计英国囊性纤维化 (CF) 患者中不同亚力克伯菌属种的流行率。
使用 nrdA 序列聚类将来自 27 家医院的 96 名患者的 147 株亚力克伯菌属分离株鉴定到种水平。通过多位点序列分型、脉冲场凝胶电泳和全基因组测序 (WGS) 研究了潜在的交叉感染。
木糖氧化无色杆菌是影响 96 名患者中 59 名 (61%) 的最常见种,其次是不显眼亚力克伯菌和迟钝亚力克伯菌 (分别为 12.4%和 8%)。确定了三个新的 nrdA 聚类。其中一个通过对内在 blaOXA 基因进行测序进一步进行了表征,揭示了新的变体。对来自同一儿科病房的四名患者的 A. insuavis 2a 分离株进行 WGS 分析表明,其中三个为 ST144,但彼此之间至少有 385 个 SNP 差异,表明交叉感染不太可能发生。
nrdA 序列聚类允许估计英国亚力克伯菌属种的流行率,突出了其他新的种,并有助于交叉感染的研究。